NY-THE-ROHATYN-GROUP
6.1.2022 13:32:06 CET | Business Wire | Press release
The Rohatyn Group (“TRG”), an asset management firm with expertise in emerging markets and real assets, announced today that it is appointing Colin Clark and Erik Kankainen as Partners. Mr. Clark, who is based in London, leads TRG’s private equity investments in Europe across a wide range of sectors. Mr. Kankainen, who is based in Boston, is responsible for the management and financial analysis of TRG’s Northern Hemisphere timber and agriculture investments. Mr. Clark and Mr. Kankainen joined the firm following the acquisitions of Citi Venture Capital International (CVCI) in 2013 and GMO Renewable Resources (GMORR) in 2017, respectively.
TRG Partner and Head of Private Markets Miguel Gutierrez said: “The addition of Colin reflects our expectation that the CEE region, along with broader peripheral Europe, offers highly compelling investment opportunities and will continue to do so in the years to come. Colin has vast experience with complex transactions, and developed and implemented a pioneering East to West European private equity strategy.”
TRG Partner and Head of Forestry and Agriculture Mike Claridge said: “Erik’s unparalleled experience in and knowledge of the timber sector has been instrumental in growing TRG’s forestry and agriculture practice. Erik has helped build out a rigorous investment management model well suited to the rapidly changing landscape for the forestry asset class.”
TRG CEO Nick Rohatyn added: “Erik and Colin both exemplify TRG’s collaborative, entrepreneurial, and determined culture. Their unique experiences contribute highly complementary perspectives and skillsets to the TRG partnership, and we are proud to recognize their hard work and talent.”
Mr. Clark has over 20 years of private equity experience in Europe spanning buy-outs and growth capital investments. He currently serves on the Amethyst Radiotherapy, Optimapharm, Prestige and Tallink Boards of Directors. Prior to joining TRG in December 2013, Mr. Clark was a Partner at CVCI and a member of the investment team from 2003. Before CVCI, Mr. Clark originated and structured project finance transactions for Citi across the EMEA region. From 1996 to 2000, he worked with Bank of Scotland in Edinburgh in various positions in project finance and acquisition finance.
Mr. Kankainen has over 15 years of experience in timber investing. Prior to its acquisition by TRG in December 2017, Mr. Kankainen was a forest investment manager for GMORR. Before joining GMORR in 2012, he was a Senior Economist in Bioenergy at Forest Economic Advisors and a Senior Analyst in Timber at RISI, Inc.
About TRG
Founded in 2002, The Rohatyn Group is an asset management firm focused on emerging markets and real assets headquartered in New York, with a global presence in 18 cities across the US, Latin America, Europe, the Middle East, India and Southeast Asia. For more information, please visit www.rohatyngroup.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220106005120/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant International and Bank Partners Achieve Real-Time Cross-Bank Liquidity Management through Tokenised Deposits via CeBM under HKMA’s EnsembleTX3.11.2026 05:10:00 CET | Press release
Transfers were among the first batch of live transactions completed under EnsembleTX, unlocking 24/7 liquidity access and near-instant settlement Following the Hong Kong Monetary Authority’s (HKMA) announcement on interbank settlement of tokenised deposit transactions under EnsembleTX, Ant International announced that it has achieved real-time cross-bank liquidity management with its key banking partners as part of its active participation in EnsembleTX. In close collaboration with Bank of China (Hong Kong) (“BOCHK”, SEHK: 2388), China Construction Bank (Asia) (“CCB (Asia)”) and HSBC (SEHK: 5), Ant International successfully completed a series of live HKD interbank transactions between September and October 2026: BOCHK interbank transactions with CCB (Asia) CCB (Asia) interbank transactions HSBC interbank transactions Executed using tokenised deposit settled through the HKMA’s Central Bank Money (CeBM), the transfers were initiated via Ant International’s proprietary blockchain-based w
SuperElastic* Material Unveiled by Angelalign2.11.2026 18:46:00 CET | Press release
New, Improved Clear Aligner Material Gives Orthodontists More Control Angelalign Technology Inc. (6699.HK) (“Angel”)http://www.angelaligner.com, a global clear aligner leader, today unveiled SuperElastic (MC-SE*), a new propietary aligner material that is a significant breakthrough in performance over its current material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261102654659/en/ Specialists in orthodontics have long asked for new aligner materials that enable better treatment for complex cases: biologically safe force levels, a large elastic working range, and strength and toughness. MC-SE* provides all of them. “Angel is commited to innovation and never settling for 'good enough'. MC-SE* is the result of seven years of materials research, testing and manufacturing optimization. The new material aims to create a new generation of aligner material that allows orthodonists to differentiate their treatment from other tre
Galderma Announces Proposed Board Appointments and Chief Financial Officer Transition2.11.2026 18:00:00 CET | Press release
The Company will hold an Extraordinary General Meeting on December 3, 2026 to further reinforce its Board of DirectorsAd hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced proposed changes to its Board of Directors, aimed at further strengthening its governance and supporting its long-term growth. The company also announced that Luigi La Corte, Chief Financial Officer (CFO), has decided to leave Galderma to pursue a significant new opportunity. Luigi La Corte will continue to fulfil his responsibilities as CFO during the transition period, supporting business continuity and a smooth handover. The company will communicate further details regarding succession arrangements and the transition timeline in due course. The Board of Directors is proposing the election of Rosalind Brewer and Petra Rumpf as new Board members. Both candidates bring extensive leadership and governance experience, alongside expertise span
Donaldson Introduces Alpha-Pore™ Technology Platform for Extended Sterile Filtration Performance2.11.2026 15:35:00 CET | Press release
Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration products and solutions, today announced Alpha‑Pore™ technology, a next generation sterile filtration platform engineered to extend filter service life while maintaining critical process performance. Built for critical applications, Alpha‑Pore technology enables longer filter run time compared with competitive single- and dual-layer polyethersulfone (PES) membrane filters, while maintaining flow characteristics, sterility assurance, and process integrity.* The platform is designed to help manufacturers improve operational efficiency through fewer changeouts and more consistent performance over time. Engineered for Extended Performance Sterile filtration processes often require balancing run time with key performance parameters such as flow, differential pressure, and contaminant retention. Alpha‑Pore technology is designed to achieve all three. By optimizing pore structure and filter architect
SBC Medical Forms Capital and Business Alliance with AtomicSoftware, Provider of the medicalforce Clinic Management Platform Used by 800+ Clinics in Japan2.11.2026 15:00:00 CET | Press release
Companies to co-develop AI features, starting with physician documentation support, to enhance medicalforce and SBC Medical’s in-house systems and drive per-clinic productivity and profitability SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that it entered into a capital and business alliance agreement on October 26, 2026, with AtomicSoftware Inc. (“AtomicSoftware”), the Tokyo-based provider of medicalforce, an all-in-one software-as-a-service (SaaS) platform for clinics. In connection with the alliance, SBC Medical has invested ¥600 million (approximately US$3.8 million) in AtomicSoftware’s Series C funding round. The two companies will co-develop AI features, beginning with a feature that supports physicians in preparing medical records. Key HighlightsProven platform: medicalforce is used by more than 800 clinics*1 in J
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom